MKI67 and neoplasm: IHC staining of tumours with proliferative markers, pH3 and Ki67 revealed expected decreases in proliferation in the APX2009-treated tumours with a 28% decrease in pH3 positivity and 3/10 tumours with limited detection of pH3 (Fig. 6d, i, P = 0.057).